BSG and benign smooth muscle neoplasm: The results of Ozler et al. are consistent with those of Kefeli et al., high EMMPRIN expression is predominantly observed in ULMS 134, indicating that EMMPRIN may serve as a useful immunohistochemical marker to distinguish LMS from other benign smooth muscle tumors.